I'm a Texas native covering the latest trends in tech, science and healthcare through explainer pieces on the breaking news team. Previously, I was a Forbes HBCU Scholar writing under the innovation and health and science teams.
Popular diabetes and weight loss drugs like Ozempic and Wegovy, known as GLP -1 medications, were not found to cause a substantial increase in the risk of developing thyroid cancer , according to one of the biggest studies to explore the link, which is the latest research to dive into the highly debated topic.) are medications designed to manage obesity and type 2 diabetes by interacting with the hunger part of the brain to suppress the appetite, and lowering blood sugar and A1C.
The researchers looked at health data for 145,410 patients living in Denmark, Sweden and Norway who were prescribed GLP-1 medications like semaglutide—the generic name for Ozempic, Wegovy and Rybelsus—and liraglutide—the generic name for Saxenda and Victoza—and another 291,667 patients who were treated with DPP4 inhibitors, another type of diabetes drug.
Each group was compared and followed for an average of about four years: 76 participants treated with GLP-1 drugs and 184 participants treated with DPP4 inhibitors developed thyroid cancer, according to the study published Tuesday in BMJ. The researchers determined that because the incidence rate was so low, GLP-1 use was not associated with a substantially increased risk of developing thyroid cancer, though they couldn’t “exclude a small increase in risk.”
The study also did a secondary analysis comparing 111,744 patients who took GLP-1 drugs to 149,179 patients who took another form of diabetes drug called SGLT2 inhibitors, and the results were consistent with the DPP4 inhibitor comparison.
Ozempic GLP-1 Novo Nordisk Thyroid Cancer Ozempic Thyroid Cancer Wegovy Thyroid Cancer Saxenda Thyroid Cancer Semaglutide Thyroid Cancer Glp-1 Thyroid Cancer
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss DrugsI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
People Unexpectedly Getting Pregnant on Ozempic and WegovyScience and Technology News and Videos
Read more »
Another Study Warns of Surgery Risks for Folks Taking Ozempic, WegovyPeople taking weight-loss drugs like Ozempic and Wegovy need to drop them in the days or weeks prior to surgery, a new study warns.
Read more »
Costco now offers weight-loss program that includes Ozempic and WegovyCostco's health partner Sesame says the program can help a person lose 5% of their body weight in three months, 10% in six months, and 15% in a year.
Read more »
Costco launches weight loss programs that could include Ozempic, WegovyCheck out all the details of the expanded health care partnership.
Read more »
The Science Behind Weight-Loss Drugs: Ozempic and WegovyExploring the effectiveness and potential side effects of weight-loss drugs Ozempic and Wegovy, both brand names of the drug semaglutide.
Read more »